Princeton, New Jersey; June 1, 2011 - Sandoz today announced the US Food and Drug Administration (FDA) approval and US launch of donepezil hydrochloride (HCL) film-coated tablets and donepezil HCL ...

(HealthDay News) – For patients with dementia with Lewy bodies (DLB), 5 and 10mg/day doses of donepezil are associated with significant improvements in behavioral, cognitive, and global symptoms, ...

Drug firm Unichem Laboratories has received approval from the US health regulator for it's Donepezil Hydrochloride tablets used for improving cognition and behaviour of people suffering with Alzheimer ...

Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...

Forest Laboratories announced that it has submitted a New Drug Application (NDA) for a fixed-dose combination (FDC) of memantine HCl extended release (ER), a receptor antagonist and donepezil HCl, ...

Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed Dosed Combination of Namenda XR® and Donepezil for Alzheimer's ...

NEW YORK & EMERYVILLE, Calif.--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical company, and Adamas Pharmaceuticals, Inc. announced today that they have entered ...

Add Yahoo as a preferred source to see more of our stories on Google. Forest Laboratories and Adamas Pharmaceuticals Enter into Licensing Agreement for the Development and Commercialization of a Fixed ...

"US subsidiary Lupin Pharmaceuticals Inc has launched its Donepezil hydrochloride tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market," ...